These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38729048)

  • 21. The CRISPR-Cas13a Gemini System for noncontiguous target RNA activation.
    Zhao H; Sheng Y; Zhang T; Zhou S; Zhu Y; Qian F; Liu M; Xu W; Zhang D; Hu J
    Nat Commun; 2024 Apr; 15(1):2901. PubMed ID: 38575571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paper-based loop-mediated isothermal amplification and CRISPR integrated platform for on-site nucleic acid testing of pathogens.
    Sen A; Masetty M; Weerakoon S; Morris C; Yadav JS; Apewokin S; Trannguyen J; Broom M; Priye A
    Biosens Bioelectron; 2024 Aug; 257():116292. PubMed ID: 38653014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas12a and aptamer-chemiluminescence based analysis for the relative abundance determination of tumor-related protein positive exosomes for breast cancer diagnosis.
    Guan X; Zhao J; Sha Z; Liang Y; Huang J; Zhang J; Sun S
    Biosens Bioelectron; 2024 Sep; 259():116380. PubMed ID: 38754193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Field-deployable viral diagnostic tools for dengue virus based on Cas13a and Cas12a.
    Tian G; Tan J; Liu B; Xiao M; Xia Q
    Anal Chim Acta; 2024 Aug; 1316():342838. PubMed ID: 38969428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cascade CRISPR/Cas12a and DSN for the electrochemical biosensing of miR-1246 in BC-derived exosomes.
    Xiao X; Tang L; Li C; Sun Z; Yao Q; Zhang GJ; Sun Y; Zhu F; Zhang Y
    Bioelectrochemistry; 2024 Oct; 159():108753. PubMed ID: 38833812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrahedral DNA framework based CRISPR electrochemical biosensor for amplification-free miRNA detection.
    Xu Y; Wang C; Liu G; Zhao X; Qian Q; Li S; Mi X
    Biosens Bioelectron; 2022 Dec; 217():114671. PubMed ID: 36122469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid and sensitive one-pot platform integrating fluorogenic RNA aptamers and CRISPR-Cas13a for visual detection of monkeypox virus.
    Wang X; Deng X; Zhang Y; Dong W; Rao Q; Huang Q; Tang F; Shen R; Xu H; Jin Z; Tang Y; Du D
    Biosens Bioelectron; 2024 Aug; 257():116268. PubMed ID: 38636316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR dual enzyme cleavage triggers DNA and RNA substrate cleavage for SARS-CoV-2 dual gene detection.
    Jiang T; Liu R; Shen J
    J Med Virol; 2023 Sep; 95(9):e29090. PubMed ID: 37695079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the CRISPR/Cas System in Pathogen Detection: A Review.
    Yuan B; Yuan C; Li L; Long M; Chen Z
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review).
    Dronina J; Samukaite-Bubniene U; Ramanavicius A
    J Nanobiotechnology; 2022 Jan; 20(1):41. PubMed ID: 35062978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
    Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of target specificity of CRISPR-Cas12a by using a chimeric DNA-RNA guide.
    Kim H; Lee WJ; Oh Y; Kang SH; Hur JK; Lee H; Song W; Lim KS; Park YH; Song BS; Jin YB; Jun BH; Jung C; Lee DS; Kim SU; Lee SH
    Nucleic Acids Res; 2020 Sep; 48(15):8601-8616. PubMed ID: 32687187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Fidelity CRISPR/Cas13a
    Zhou T; Huang M; Lin J; Huang R; Xing D
    Anal Chem; 2021 Feb; 93(4):2038-2044. PubMed ID: 33411517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA reporter based CRISPR/Cas12a biosensing platform for sensitive detection of circulating tumor DNA.
    Deng F; Li Y; Sang R; Zhang C; Hall T; Yang D; Goldys E
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: A promising method in the point-of-care detection.
    Chen Y; Shi Y; Chen Y; Yang Z; Wu H; Zhou Z; Li J; Ping J; He L; Shen H; Chen Z; Wu J; Yu Y; Zhang Y; Chen H
    Biosens Bioelectron; 2020 Dec; 169():112642. PubMed ID: 32979593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
    Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
    Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.
    Shu X; Zhang D; Li X; Zheng Q; Cai X; Ding S; Yan Y
    ACS Synth Biol; 2022 Aug; 11(8):2829-2836. PubMed ID: 35946354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel label-free universal biosensing platform based on CRISPR/Cas12a for biomarker detection.
    Mu X; Wang X; Qin Y; Huang Y; Tian J; Zhao S
    Talanta; 2023 Jan; 251():123795. PubMed ID: 35952502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas13a induced exponential amplification for highly sensitive and specific detection of circular RNA.
    Song P; Zhang P; Qin K; Su F; Gao K; Liu X; Li Z
    Talanta; 2022 Aug; 246():123521. PubMed ID: 35533568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.